Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

J. Sweeney, Christopher; Chen, Yu‐Hui; A. Carducci, Michael; Liu, Glenn; F. Jarrard, David; A. Eisenberger, Mario; Wong, Yu-Ning; M. Hahn, Noah; Kohli, Manish; M. Cooney, Matthew; Dreicer, Robert; J. Vogelzang, Nicholas; Picus, Joel; H. Shevrin, Daniel; Hussain, Maha; A. García, Jorge; S. DiPaola, Robert

doi:10.1056/nejmoa1503747

Public

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

Published in New England Journal of Medicine • Aug 5, 2015

Authors:

Christopher J. Sweeney

Yu‐Hui Chen

Michael A. Carducci

Abstract

BACKGROUND: Androgen-deprivation therapy (ADT) has been the backbone of treatment for metastatic prostate cancer since the 1940s. We assessed whether concomitant treatment with ADT plus docetaxel would result in longer overall survival than that with ADT alone. METHODS: We assigned men with metastat...

Subject

Androgen deprivation therapy

Prostate cancer

Docetaxel

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!